TENAX THERAPEUTICS, INC. (TENX) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 5 insider purchases totalling $4.8M. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 filed Sept. 11, 2026 | Giordano Christopher Thomas CEO | +$20,087 | 10,850 | +96% | No | |
|
|
||||||
| Sept. 15, 2026 filed Sept. 11, 2026 | STAAB THOMAS R II Chief Financial Officer | +$10,981 | 5,675 | +57% | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 3, 2026 | ADAR1 Capital Management, LLC 10% Owner | +$1,604,160 | 900,000 | +16% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | ADAR1 Capital Management, LLC 10% Owner | +$1,381,750 | 770,333 | +16% | No | |
|
|
||||||
| Aug. 24, 2026 filed Aug. 20, 2026 | ADAR1 Capital Management, LLC 10% Owner | +$1,814,147 | 1,025,867 | +27% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free